NOS3 and atherosclerosis: CyPA is known to promote atherosclerosis through stimulation of low-density lipoprotein uptake, decrease of endothelial nitric oxide synthase (eNOS) expression, increase of vascular cell adhesion molecule 1 (VCAM-1), and induction of tumor necrosis factor alpha (TNFα) (178).